<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Int. J. Infect. Dis</journal-id><journal-title-group><journal-title>International Journal of Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">1201-9712</issn><issn pub-type="epub">1878-3511</issn><publisher><publisher-name>Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7301795</article-id><article-id pub-id-type="publisher-id">S1201-9712(20)30491-4</article-id><article-id pub-id-type="doi">10.1016/j.ijid.2020.06.056</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Mini-review of the literature</article-title></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>D&#x02019;Abramo</surname><given-names>Alessandra</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="fn0005" ref-type="fn">1</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Lepore</surname><given-names>Luciana</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="fn0005" ref-type="fn">1</xref></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Palazzolo</surname><given-names>Claudia</given-names></name><email>claudia.palazzolo@inmi.i</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="aut0020"><name><surname>Barreca</surname><given-names>Filippo</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="aut0025"><name><surname>Liuzzi</surname><given-names>Giuseppina</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="aut0030"><name><surname>Lalle</surname><given-names>Eleonora</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="aut0035"><name><surname>Nicastri</surname><given-names>Emanuele</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><aff id="aff0005"><label>a</label>National Institute for Infectious Diseases &#x02018;Lazzaro Spallanzani&#x02019;, IRCCS, via Portuense 292, 00149, Rome, Italy</aff><aff id="aff0010"><label>b</label>Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, viale Oxford 81, 00133, Rome, Italy</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding author. <email>claudia.palazzolo@inmi.i</email></corresp><fn id="fn0005"><label>1</label><p id="npar0005">Drs D&#x02019;Abramo and Lepore equally contributed.</p></fn></author-notes><pub-date pub-type="pmc-release"><day>18</day><month>6</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>8</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>18</day><month>6</month><year>2020</year></pub-date><volume>97</volume><fpage>236</fpage><lpage>239</lpage><history><date date-type="received"><day>23</day><month>4</month><year>2020</year></date><date date-type="rev-recd"><day>13</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>6</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder/><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract abstract-type="author-highlights" id="abs0005"><title>Highlights</title><p><list list-type="simple" id="lis0005"><list-item id="lsti0005"><label>&#x02022;</label><p id="par0005">Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection.</p></list-item><list-item id="lsti0010"><label>&#x02022;</label><p id="par0010">Challenging in co-infection cases identification.</p></list-item><list-item id="lsti0015"><label>&#x02022;</label><p id="par0015">Improvement of preventive measures and patients&#x02019; clinical outcome.</p></list-item></list></p></abstract><abstract id="abs0010"><p>A case of acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection and a mini-review of the literature is reported. Even in COVID-19 epidemics, the early identification of concurrent respiratory pathogens is important to improve etiological diagnosis, preventive measures and patients&#x02019; clinical management and outcome.</p></abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>Acute respiratory distress syndrome</kwd><kwd>SARS-CoV-2</kwd><kwd>Influenza A</kwd><kwd>COVID-19 epidemic</kwd></kwd-group></article-meta></front><body><sec id="sec0005"><title>Introduction</title><p id="par0020">In December 2019, a novel coronavirus, the severe acute respiratory syndrome coronavirus-2 (SARS- CoV-2) which causes a human disease named coronavirus disease (COVID-19) was identified in the pneumonia outbreaks in Wuhan, China, in December 2019 (<xref rid="bib0025" ref-type="bibr">Chan et al., 2020</xref>). It is currently expanding rapidly to several countries all-around the word, on February 21 the first person-to-person transmission in Italy was reported (<xref rid="bib0115" ref-type="bibr">Spina et al., 2020</xref>). Here, we report a case of SARS-CoV-2 and Influenza A co-infection and a mini-review of the literature.</p></sec><sec id="sec0010"><title>Case presentation</title><p id="par0025">A 56 year-old male general surgeon was admitted to the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, Italy, on March 6, 2020. He was a smoker, within the overweight range (29-body mass index), with a history of two episodes of acute myocardial infarction treated with coronary angioplasty and stenting, For 4 days, he had been complaining of fever, diarrhea and asthenia after winter ski week in Northern Italy. Two days after the onset of symptoms, a nasopharyngeal swab was positive for SARS-CoV-2 (genes E and S) and Influenza A. On March 6, a chest computed tomography (CT) scan revealed bilateral and multiples peripheral ground glass opacities. Blood tests showed lymphopenia (lymphocyte and monocyte cell count: 0.67 and 0.09 &#x000d7; 109/L respectively), C- reactive protein and serum fibrinogen levels were increased (43.3 g/L and 7980 g/L respectively). An arterial oxygen tension (PaO2)/fractional inspired oxygen (FiO2) P/F Ratio was 320. Oral oseltamivir (75 mg twice per day for 5 days) and lopinavir/ritonavir (400/100 mg twice per days for 14 days) were started together with antibiotic therapy (intravenous ceftriaxone 2 gr and oral azithromycin 500 mg per day) and intravenous methylprednisolone (40 mg twice daily for 5 days with tapered discontinuation). On day eight of hospitalization, he developed respiratory failure (P/F Ratio dropped to 202) and a second chest CT scan showed a worsening of the bilateral ground-glass opacities with fibrotic consolidation in both lower pulmonary lobes (<xref rid="fig0005" ref-type="fig">Figure 1</xref>
a). At that time, nasopharyngeal swabs were positive for SARS-CoV-2, only. The patient was transferred to the Intensive Care Unit (ICU) and non-invasive ventilation through continuous positive airway pressure (C-PAP) mask was started with positive end-expiratory pressure (PEEP) 7.5 mmHg and FiO2 40%. After three days, he was re-admitted to the High Isolation Unit and discharged in good clinical conditions with persistently negative nasopharyngeal swabs. A SARS-CoV-2 serology by an in house indirect immunofluorescence assay (IgA 1:1280, IgM 1:320 and IgG 1:80) was positive (<xref rid="bib0040" ref-type="bibr">Colavita et al., 2019</xref>). During the following week, low-grade fever re-occurred with nocturnal sweats, a third CT scan showed a reduction of the ground glass areas with residual interstitial damage (<xref rid="fig0005" ref-type="fig">Figure 1</xref>b) and a further nasopharyngeal swab was negative. Symptoms healed spontaneously few days later.<fig id="fig0005"><label>Figure 1</label><caption><p>Chest computer tomography scan at patient&#x02019;s worsening and recovery.</p><p>(a) Bilateral ground-glass opacities with fibrotic consolidation in both lower pulmonary lobes (b) reduction of the ground glass areas with residual interstitial damage.</p></caption><alt-text id="at0065">Figure 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p></sec><sec id="sec0015"><title>Discussion</title><p id="par0030">Previous cases of viral pneumonia SARS-CoV-2 and influenza coinfection have been reported in literature. During the new coronavirus epidemic, a total number of 37 cases were described. <xref rid="tbl0005" ref-type="table">Table 1</xref>
summarizes the characteristics of the coinfected patients.&#x02028;Fourteen cases belonged to epidemiological studies and clinical data were not available. All patients had a similar clinical presentation (fever, cough and shortness of breath) and 9 of them (9/37, 24.3%) presented a progressive worsening with ARDS. Furthermore, six patients needed ICU monitoring and were subsequently discharged in good clinical conditions with the exception of three patients who died.<table-wrap position="float" id="tbl0005"><label>Table 1</label><caption><p>Clinical characteristics of SARS-CoV-2 and influenza coinfection, COVID-19 epidemic.</p></caption><alt-text id="at0070">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">References</th><th align="left">Sex</th><th align="left">Age</th><th align="left">Comorbidities</th><th align="left">Coinfection</th><th align="left">Oseltamivir</th><th align="left">Antivirals</th><th align="left">Glucorticoids</th><th align="left">ARDS</th><th align="left">ICU</th><th align="left">NIV</th><th align="left">IMV</th><th align="left">Outcome</th></tr></thead><tbody><tr><td align="left"><xref rid="bib0005" ref-type="bibr">Azekawa et al. (2020)</xref></td><td align="left">F</td><td align="left">78</td><td align="left">Dyslipidemia, hypothyroidism</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left"><xref rid="bib0010" ref-type="bibr">Blasco et al. (2020)</xref></td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">Influenza A and RSV</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left" valign="middle" rowspan="4"><xref rid="bib0045" ref-type="bibr">Cuadrado-Pay&#x000e1;n et al. (2020)</xref></td><td align="left">M</td><td align="left">53</td><td align="left">ERSD</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">NA</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">Yes</td><td align="left">Survived</td></tr><tr><td align="left">M</td><td align="left">78</td><td align="left">T2DM</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">NA</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">Yes</td><td align="left">Survived</td></tr><tr><td align="left">M</td><td align="left">56</td><td align="left">T2DM</td><td align="left">Influenza A and B</td><td align="left">No</td><td align="left">No</td><td align="left">NA</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">F</td><td align="left">81</td><td align="left">ERSD</td><td align="left">Influenza B</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">NA</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">Yes</td><td align="left">Survived</td></tr><tr><td align="left"><xref rid="bib0050" ref-type="bibr">de Souza Luna et al. (2020)</xref></td><td align="left">NA</td><td align="left">36</td><td align="left">NA</td><td align="left">Influenza B</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left" valign="middle" rowspan="5"><xref rid="bib0055" ref-type="bibr">Ding et al. (2020)</xref></td><td align="left">F</td><td align="left">47</td><td align="left">None</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">M</td><td align="left">50</td><td align="left">Hypertension, cancer</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">Yes</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">F</td><td align="left">66</td><td align="left">Hypertension, CVD, HBV</td><td align="left">Influenza B</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">M</td><td align="left">39</td><td align="left">HBV</td><td align="left">Influenza B</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">F</td><td align="left">49</td><td align="left">None</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left"><xref rid="bib0060" ref-type="bibr">Garazzino et al. (2020)</xref></td><td align="left">NA</td><td align="left">&#x0003c;17</td><td align="left">NA</td><td align="left">Influenza A</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left" valign="middle" rowspan="2"><xref rid="bib0065" ref-type="bibr">Hashemi et al. (2020)</xref></td><td align="left">F</td><td align="left">78</td><td align="left">NA</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">NA</td><td align="left">Yes</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">Dead</td></tr><tr><td align="left">M</td><td align="left">75</td><td align="left">NA</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">NA</td><td align="left">Yes</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">Dead</td></tr><tr><td align="left" valign="middle" rowspan="4"><xref rid="bib0070" ref-type="bibr">Khodamoradi et al. (2020)</xref></td><td align="left">F</td><td align="left">74</td><td align="left">Hypertension, CVD</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">M</td><td align="left">40</td><td align="left">None</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">M</td><td align="left">64</td><td align="left">None</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">M</td><td align="left">50</td><td align="left">None</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left"><xref rid="bib0075" ref-type="bibr">Kim et al. (2020)</xref></td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">Influenza A</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left" valign="middle" rowspan="3"><xref rid="bib0085" ref-type="bibr">Konala et al. (2020b)</xref></td><td align="left">M</td><td align="left">57</td><td align="left">Hypertension, T2DM, CVD, AICD</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">F</td><td align="left">35</td><td align="left">Sickle cell trait</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left">F</td><td align="left">68</td><td align="left">T2DM, hypertension, GERD</td><td align="left">Influenza B</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">NA</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">Yes</td><td align="left">Dead</td></tr><tr><td align="left"><xref rid="bib0080" ref-type="bibr">Konala et al. (2020a)</xref></td><td align="left">F</td><td align="left">66</td><td align="left">T2DM, CVD, hypertension, CKD</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">NA</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">Yes</td><td align="left">Survived</td></tr><tr><td align="left"><xref rid="bib0100" ref-type="bibr">Nowak et al. (2020)</xref></td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">Influenza A</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left"><xref rid="bib0105" ref-type="bibr">Pongpirul et al. (2020)</xref></td><td align="left">M</td><td align="left">61</td><td align="left">None</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left"><xref rid="bib0110" ref-type="bibr">Richardson et al. (2020)</xref></td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">Influenza A</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left"><xref rid="bib0125" ref-type="bibr">Wehl et al. (2020)</xref></td><td align="left">NA</td><td align="left">4 months</td><td align="left">None</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">No</td><td align="left">Survived</td></tr><tr><td align="left"><xref rid="bib0135" ref-type="bibr">Wu et al. (2020b)</xref></td><td align="left">NA</td><td align="left">&#x0003c;17</td><td align="left">NA</td><td align="left">MP, Influenza A&#x00026;B, RSV</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left"><xref rid="bib0140" ref-type="bibr">Wu et al. (2020c)</xref></td><td align="left">M</td><td align="left">69</td><td align="left">None</td><td align="left">Influenza A</td><td align="left">Yes</td><td align="left">NA</td><td align="left">NA</td><td align="left">Yes</td><td align="left">Yes</td><td align="left">No</td><td align="left">Yes</td><td align="left">Survived</td></tr><tr><td align="left"><xref rid="bib0145" ref-type="bibr">Zhu et al. (2020)</xref></td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">2 pts Influenza A</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">5 pts Influenza B</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><fn><p>SARS-CoV-2: severe acute respiratory syndrome coronavirus-2, COVID-19: coronavirus disease-19, CVD: cardiovascular disease, HBV: hepatitis B virus, NA: not available, ARDS; Acute Respiratory Distress Syndrome, ICU: Intensive Care Unit, NIV: non-invasive ventilation, IMV: invasive mechanical ventilation, T2DM: type 2 diabetes mellitus. AICD: automatic implantable cardioverter defibrillator. RSV: Respiratory syncytial virus. MP: Mycoplasma pneumonia. ESRD: end-stage kidney disease. CKD: chronic kidney disease. GERD: gastroesophageal reflux disease.</p></fn></table-wrap-foot></table-wrap></p><p id="par0035">Even during a pandemic scenario, several respiratory pathogens should be considered in the diagnostic algorithm, for an early etiological identification and appropriate treatment. SARS-CoV-2 and influenza viruses share common route of transmission, same season occurrence and overlapping clinical features (<xref rid="bib0090" ref-type="bibr">Lai et al., 2020</xref>, <xref rid="bib0030" ref-type="bibr">Chow et al., 2019</xref>). Indeed, SARS-CoV-2 exhibits prevalent human-to-human transmission through close contact with an estimated R0 of 3.28 and a median of 2.79 with IQR of 1.6 (<xref rid="bib0095" ref-type="bibr">Liu et al., 2020</xref>).</p><p id="par0040">Respiratory symptoms are always the initial manifestations of both SARS-CoV-2 and influenza infections which could progress towards ARDS. Recently, ground-glass opacities and a higher median PaO2/FIO2 (198.2 vs 107.0) were observed in COVID-19-induced ARDS rather than H1N1 patients (<xref rid="bib0120" ref-type="bibr">Tang et al., 2020</xref>).</p><p id="par0045">Nevertheless, a timely identification of the two co-infections is needed in relation to difference in treatments and prognosis. Antiviral therapy is currently available for influenza infection (i.e. oseltamivir, zanamivir, and peramivir) while experimental off-label drugs (i.e. lopinavir/ritonavir, chloroquine, and hydroxychloroquine) have been commonly used in COVID-19 treatment. In particular, the boosted protease inhibitor lopinavir/ritonavir has been previously associated with significantly fewer adverse clinical outcomes for the treatment of SARS and furthermore, in association with the Interferon Beta-1b, it has been demonstrated to be beneficial in animal studies against the Middle East Respiratory Syndrome (<xref rid="bib0035" ref-type="bibr">Chu et al., 2004</xref>, <xref rid="bib0020" ref-type="bibr">Chan et al., 2015</xref>). Considering the severity of the clinical picture and the prompt availability of lopinavir/ritonavir in our Institute, clinicians opted for this treatment although the antiviral effects remain to be determined (<xref rid="bib0015" ref-type="bibr">Cao et al., 2020</xref>).</p><p id="par0050">Despite a recent report on beneficial effect of steroids treatment in COVID-19 patients who develop ARDS, its routinely use remains controversial with lack of an accurate assessment of the harm/benefit balance (<xref rid="bib0130" ref-type="bibr">Wu et al., 2020a</xref>).</p><p id="par0055">The epidemiological situation in Italy in February 2020 and the recommendations in use at that time allowed a timely identification of our patient with a prompt hospitalization and subsequent diagnostic investigations. Therefore, the early antiviral treatments of both influenza and SARS-CoV-2, together with a brief steroid course and oxygen supplementation, had an impact on the patient&#x02019;s outcome avoiding the progressive worsening and the evolution towards the severe ARDS phase. In conclusion, even in epidemic setting, the early and prompt identification of concurrent respiratory pathogens is important in order to improve etiological diagnosis, preventive measures and patients&#x02019; clinical management and outcome. Further studies are needed to better understand the pathogenic role of viral coinfections in respiratory diseases.</p></sec><sec id="sec0020"><title>Funding</title><p id="par0060">This paper was funded by R<funding-source id="gs0005">icerca Corrente Line1</funding-source>on emerging and re-emerging infections funded by the <funding-source id="gs0010">Italian Ministry of Health</funding-source>.</p></sec><sec id="sec0025"><title>Ethical approval</title><p id="par0065">This study was approved by the Spallanzani Institute Ethical Board and patient&#x02019;s written informed consent for publication was collected</p></sec><sec id="sec0030"><title>Conflict of interest</title><p id="par0070">All authors have no conflict of interest to declare.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0005"><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Azekawa</surname><given-names>S.</given-names></name><name><surname>Namkoong</surname><given-names>H.</given-names></name><name><surname>Mitamura</surname><given-names>K.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name><name><surname>Saito</surname><given-names>F.</given-names></name></person-group><article-title>Co-infection with SARS-CoV-2 and influenza A virus</article-title><source>IDCases</source><volume>20</volume><issue>April</issue><year>2020</year><object-id pub-id-type="publisher-id">e00775</object-id><pub-id pub-id-type="doi">10.1016/j.idcr.2020.e00775</pub-id></element-citation></ref><ref id="bib0010"><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Blasco</surname><given-names>M.L.</given-names></name><name><surname>Buesa</surname><given-names>J.</given-names></name><name><surname>Colomina</surname><given-names>J.</given-names></name><name><surname>Forner</surname><given-names>M.J.</given-names></name><name><surname>Galindo</surname><given-names>M.J.</given-names></name><name><surname>Navarro</surname><given-names>J.</given-names></name></person-group><article-title>Co-detection of respiratory pathogens in patients hospitalized with coronavirus viral disease-2019 pneumonia</article-title><source>J Med Virol</source><issue>April</issue><year>2020</year><pub-id pub-id-type="doi">10.1002/jmv.25922</pub-id></element-citation></ref><ref id="bib0015"><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name></person-group><article-title>A trial of lopinavir&#x02013;ritonavir in adults hospitalized with severe Covid-19</article-title><source>N Engl J Med</source><volume>382</volume><issue>May (19)</issue><year>2020</year><fpage>1787</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2001282</pub-id><pub-id pub-id-type="pmid">32187464</pub-id></element-citation></ref><ref id="bib0020"><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.F.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Yeung</surname><given-names>M.L.</given-names></name><name><surname>Deng</surname><given-names>W.</given-names></name><name><surname>Bao</surname><given-names>L.</given-names></name><name><surname>Jia</surname><given-names>L.</given-names></name></person-group><article-title>Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset</article-title><source>J Infect Dis</source><volume>212</volume><issue>12</issue><year>2015</year><fpage>1904</fpage><lpage>1913</lpage><pub-id pub-id-type="pmid">26198719</pub-id></element-citation></ref><ref id="bib0025"><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.F.</given-names></name><name><surname>Kok</surname><given-names>K.H.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Chu</surname><given-names>H.</given-names></name><name><surname>To</surname><given-names>K.K.</given-names></name><name><surname>Yuan</surname><given-names>S.</given-names></name></person-group><article-title>Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</article-title><source>Emerg Microbes Infect</source><volume>9</volume><issue>January (1)</issue><year>2020</year><fpage>221</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1080/22221751.2020.1719902</pub-id><pub-id pub-id-type="pmid">31987001</pub-id></element-citation></ref><ref id="bib0030"><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>E.J.</given-names></name><name><surname>Doyle</surname><given-names>J.D.</given-names></name><name><surname>Uyeki</surname><given-names>T.M.</given-names></name></person-group><article-title>Influenza virus-related critical illness: prevention, diagnosis, treatment</article-title><source>Crit Care</source><volume>23</volume><issue>June (1)</issue><year>2019</year><fpage>214</fpage><pub-id pub-id-type="doi">10.1186/s13054-019-2491-9</pub-id><pub-id pub-id-type="pmid">31189475</pub-id></element-citation></ref><ref id="bib0035"><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>C.M.</given-names></name><name><surname>Cheng</surname><given-names>V.C.</given-names></name><name><surname>Hung</surname><given-names>I.F.</given-names></name><name><surname>Wong</surname><given-names>M.M.</given-names></name><name><surname>Chan</surname><given-names>K.H.</given-names></name><name><surname>Chan</surname><given-names>K.S.</given-names></name></person-group><article-title>Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings</article-title><source>Thorax</source><volume>59</volume><issue>3</issue><year>2004</year><fpage>252</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">14985565</pub-id></element-citation></ref><ref id="bib0040"><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Colavita</surname><given-names>F.</given-names></name><name><surname>Biava</surname><given-names>M.</given-names></name><name><surname>Castilletti</surname><given-names>C.</given-names></name><name><surname>Lanini</surname><given-names>S.</given-names></name><name><surname>Miccio</surname><given-names>R.</given-names></name><name><surname>Portella</surname><given-names>G.</given-names></name></person-group><article-title>Inflammatory and humoral immune response during Ebola virus infection in survivor and fatal cases occurred in Sierra Leone during the 2014&#x02013;2016 outbreak in West Africa</article-title><source>Viruses</source><volume>11</volume><year>2019</year><fpage>373</fpage><comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/1999-4915/11/4/373" id="intr0005">https://www.mdpi.com/1999-4915/11/4/373</ext-link></comment></element-citation></ref><ref id="bib0045"><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Cuadrado-Pay&#x000e1;n</surname><given-names>E.</given-names></name><name><surname>Montagud-Marrahi</surname><given-names>E.</given-names></name><name><surname>Torres-Elorza</surname><given-names>M.</given-names></name><name><surname>Bodro</surname><given-names>M.</given-names></name><name><surname>Blasco</surname><given-names>M.</given-names></name><name><surname>Poch</surname><given-names>E.</given-names></name></person-group><article-title>SARS-CoV-2 and influenza virus co-infection</article-title><source>Lancet</source><volume>395</volume><issue>May (10236)</issue><year>2020</year><fpage>e84</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31052-7</pub-id><pub-id pub-id-type="pmid">32423586</pub-id></element-citation></ref><ref id="bib0050"><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>de Souza Luna</surname><given-names>L.K.</given-names></name><name><surname>Perosa</surname><given-names>D.A.H.</given-names></name><name><surname>Conte</surname><given-names>D.D.</given-names></name><name><surname>Carvalho</surname><given-names>J.M.A.</given-names></name><name><surname>Alves</surname><given-names>V.R.G.</given-names></name><name><surname>Cruz</surname><given-names>J.S.</given-names></name></person-group><article-title>Different patterns of influenza A and B detected during early stages of COVID-19 in a University Hospital in S&#x000e3;o Paulo, Brazil</article-title><source>J Infect</source><issue>May</issue><year>2020</year><pub-id pub-id-type="doi">10.1016/j.jinf.2020.05.036</pub-id><comment>S0163-4453(20)30313-3</comment></element-citation></ref><ref id="bib0055"><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Q.</given-names></name><name><surname>Lu</surname><given-names>P.</given-names></name><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name></person-group><article-title>The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China</article-title><source>J Med Virol</source><issue>March</issue><year>2020</year><pub-id pub-id-type="doi">10.1002/jmv.25781</pub-id></element-citation></ref><ref id="bib0060"><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Garazzino</surname><given-names>S.</given-names></name><name><surname>Montagnani</surname><given-names>C.</given-names></name><name><surname>Don&#x000e0;</surname><given-names>D.</given-names></name><name><surname>Meini</surname><given-names>A.</given-names></name><name><surname>Felici</surname><given-names>E.</given-names></name><name><surname>Vergine</surname><given-names>G.</given-names></name></person-group><article-title>Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020</article-title><source>Euro Surveill</source><volume>25</volume><issue>May (18)</issue><year>2020</year><object-id pub-id-type="publisher-id">2000600</object-id><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.25.18.2000600</pub-id></element-citation></ref><ref id="bib0065"><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>S.A.</given-names></name><name><surname>Safamanesh</surname><given-names>S.</given-names></name><name><surname>Ghafouri</surname><given-names>M.</given-names></name><name><surname>Taghavi</surname><given-names>M.R.</given-names></name><name><surname>Mohajer Zadeh Heydari</surname><given-names>M.S.</given-names></name><name><surname>Namdar Ahmadabad</surname><given-names>H.</given-names></name></person-group><article-title>Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran</article-title><source>J Med Virol</source><issue>May</issue><year>2020</year><pub-id pub-id-type="doi">10.1002/jmv.26014</pub-id></element-citation></ref><ref id="bib0070"><element-citation publication-type="journal" id="sbref0070"><person-group person-group-type="author"><name><surname>Khodamoradi</surname><given-names>Z.</given-names></name><name><surname>Moghadami</surname><given-names>M.</given-names></name><name><surname>Lotfi</surname><given-names>M.</given-names></name></person-group><article-title>Co-infection of coronavirus disease 2019 and influenza A: a report from Iran</article-title><source>Arch Iran Med</source><volume>23</volume><issue>April (4)</issue><year>2020</year><fpage>239</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.34172/aim.2020.04</pub-id><pub-id pub-id-type="pmid">32271596</pub-id></element-citation></ref><ref id="bib0075"><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Quinn</surname><given-names>J.</given-names></name><name><surname>Pinsky</surname><given-names>B.</given-names></name><name><surname>Shah</surname><given-names>N.H.</given-names></name><name><surname>Brown</surname><given-names>I.</given-names></name></person-group><article-title>Rates of co-infection between SARS-CoV-2 and other respiratory pathogens</article-title><source>JAMA</source><volume>323</volume><issue>April (20)</issue><year>2020</year><fpage>2085</fpage><lpage>2086</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.6266</pub-id></element-citation></ref><ref id="bib0080"><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Konala</surname><given-names>V.M.</given-names></name><name><surname>Adapa</surname><given-names>S.</given-names></name><name><surname>Gayam</surname><given-names>V.</given-names></name><name><surname>Naramala</surname><given-names>S.</given-names></name><name><surname>Daggubati</surname><given-names>S.R.</given-names></name><name><surname>Kammari</surname><given-names>C.B.</given-names></name></person-group><article-title>Co-infection with influenza A and COVID-19</article-title><source>Eur J Case Rep Intern Med</source><volume>7</volume><issue>April (5)</issue><year>2020</year><object-id pub-id-type="publisher-id">001656</object-id><pub-id pub-id-type="doi">10.12890/2020_001656</pub-id></element-citation></ref><ref id="bib0085"><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Konala</surname><given-names>V.M.</given-names></name><name><surname>Adapa</surname><given-names>S.</given-names></name><name><surname>Naramala</surname><given-names>S.</given-names></name><name><surname>Chenna</surname><given-names>A.</given-names></name><name><surname>Lamichhane</surname><given-names>S.</given-names></name><name><surname>Garlapati</surname><given-names>P.R.</given-names></name></person-group><article-title>A case series of patients coinfected with influenza and COVID-19</article-title><source>J Investig Med High Impact Case Rep</source><volume>8</volume><issue>January&#x02013;December</issue><year>2020</year><object-id pub-id-type="publisher-id">2324709620934674</object-id><pub-id pub-id-type="doi">10.1177/2324709620934674</pub-id></element-citation></ref><ref id="bib0090"><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>C.C.</given-names></name><name><surname>Liu</surname><given-names>Y.H.</given-names></name><name><surname>Wang</surname><given-names>C.Y.</given-names></name><name><surname>Wang</surname><given-names>Y.H.</given-names></name><name><surname>Hsueh</surname><given-names>S.C.</given-names></name><name><surname>Yen</surname><given-names>M.Y.</given-names></name></person-group><article-title>Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths</article-title><source>J Microbiol Immunol Infect</source><issue>March</issue><year>2020</year><pub-id pub-id-type="doi">10.1016/j.jmii.2020.02.012</pub-id><comment>pii: S1684-1182(20)30040-30042</comment></element-citation></ref><ref id="bib0095"><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Gayle</surname><given-names>A.A.</given-names></name><name><surname>Wilder-Smith</surname><given-names>A.</given-names></name><name><surname>Rockl&#x000f6;v</surname><given-names>J.</given-names></name></person-group><article-title>The reproductive number of COVID-19 is higher compared to SARS coronavirus</article-title><source>J Travel Med</source><volume>27</volume><year>2020</year><object-id pub-id-type="publisher-id">taaa02</object-id><pub-id pub-id-type="doi">10.1093/jtm/taaa021</pub-id></element-citation></ref><ref id="bib0100"><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>M.D.</given-names></name><name><surname>Sordillo</surname><given-names>E.M.</given-names></name><name><surname>Gitman</surname><given-names>M.R.</given-names></name><name><surname>Paniz Mondolfi</surname><given-names>A.E.</given-names></name></person-group><article-title>Co-infection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus/enterovirus?</article-title><source>J Med Virol</source><issue>April</issue><year>2020</year><pub-id pub-id-type="doi">10.1002/jmv.25953</pub-id></element-citation></ref><ref id="bib0105"><element-citation publication-type="journal" id="sbref0105"><person-group person-group-type="author"><name><surname>Pongpirul</surname><given-names>W.A.</given-names></name><name><surname>Mott</surname><given-names>J.A.</given-names></name><name><surname>Woodring</surname><given-names>J.V.</given-names></name><name><surname>Uyeki</surname><given-names>T.M.</given-names></name><name><surname>MacArthur</surname><given-names>J.R.</given-names></name><name><surname>Vachiraphan</surname><given-names>A.</given-names></name></person-group><article-title>Clinical characteristics of patients hospitalized with coronavirus disease, Thailand</article-title><source>Emerg Infect Dis</source><volume>26</volume><issue>April (7)</issue><year>2020</year><pub-id pub-id-type="doi">10.3201/eid2607.200598</pub-id></element-citation></ref><ref id="bib0110"><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>S.</given-names></name><name><surname>Hirsch</surname><given-names>J.S.</given-names></name><name><surname>Narasimhan</surname><given-names>M.</given-names></name><name><surname>Crawford</surname><given-names>J.M.</given-names></name><name><surname>McGinn</surname><given-names>T.</given-names></name><name><surname>Davidson</surname><given-names>K.W.</given-names></name></person-group><article-title>Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area</article-title><source>JAMA</source><volume>323</volume><issue>April (20)</issue><year>2020</year><fpage>2052</fpage><lpage>2059</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.6775</pub-id></element-citation></ref><ref id="bib0115"><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Spina</surname><given-names>S.</given-names></name><name><surname>Marrazzo</surname><given-names>F.</given-names></name><name><surname>Migliari</surname><given-names>M.</given-names></name><name><surname>Stucchi</surname><given-names>R.</given-names></name><name><surname>Sforza</surname><given-names>A.</given-names></name><name><surname>Fumagalli</surname><given-names>R.</given-names></name></person-group><article-title>The response of Milan&#x02019;s Emergency Medical System to the COVID-19 outbreak in Italy</article-title><source>Lancet</source><volume>395</volume><issue>March (10227)</issue><year>2020</year><fpage>e49</fpage><lpage>e50</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30493-1</pub-id><pub-id pub-id-type="pmid">32119824</pub-id></element-citation></ref><ref id="bib0120"><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Du</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Cao</surname><given-names>T.</given-names></name><name><surname>Guan</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name></person-group><article-title>Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N</article-title><source>Chest</source><issue>March</issue><year>2020</year><pub-id pub-id-type="doi">10.1016/j.chest.2020.03.032</pub-id><comment>pii: S0012-3692(20)30558-4</comment></element-citation></ref><ref id="bib0125"><element-citation publication-type="journal" id="sbref0125"><person-group person-group-type="author"><name><surname>Wehl</surname><given-names>G.</given-names></name><name><surname>Laible</surname><given-names>M.</given-names></name><name><surname>Rauchenzauner</surname><given-names>M.</given-names></name></person-group><article-title>Co-infection of SARS CoV-2 and influenza A in a pediatric patient in Germany</article-title><source>Klin Padiatr</source><issue>May</issue><year>2020</year><pub-id pub-id-type="doi">10.1055/a-1163-7385</pub-id><comment>Online ahead of print</comment></element-citation></ref><ref id="bib0130"><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name></person-group><article-title>Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China</article-title><source>JAMA Intern Med</source><issue>March</issue><year>2020</year><pub-id pub-id-type="doi">10.1001/jamainternmed.2020.0994</pub-id></element-citation></ref><ref id="bib0135"><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Xing</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Pan</surname><given-names>S.</given-names></name></person-group><article-title>Coinfection and other clinical characteristics of COVID-19 in children</article-title><source>Pediatrics</source><issue>May</issue><year>2020</year><object-id pub-id-type="publisher-id">e20200961</object-id><pub-id pub-id-type="doi">10.1542/peds.2020-0961</pub-id></element-citation></ref><ref id="bib0140"><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name></person-group><article-title>Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China</article-title><source>Emerg Infect Dis</source><volume>26</volume><issue>June (6)</issue><year>2020</year><fpage>1324</fpage><lpage>1326</lpage><pub-id pub-id-type="doi">10.3201/eid2606.200299</pub-id><pub-id pub-id-type="pmid">32160148</pub-id></element-citation></ref><ref id="bib0145"><element-citation publication-type="journal" id="sbref0145"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name></person-group><article-title>Co-infection with respiratory pathogens among COVID-2019 cases</article-title><source>Virus Res</source><volume>285</volume><issue>May</issue><year>2020</year><object-id pub-id-type="publisher-id">198005</object-id><pub-id pub-id-type="doi">10.1016/j.virusres.2020.198005</pub-id></element-citation></ref></ref-list></back></article>